# CLOTRIMAZOLE
> **ANDA215641** · Abbreviated New Drug Application (Generic) · Sponsor: THINQ PHARM-CRO PVT · Approved 2024-02-29
## Drug
- **FDA Application Number:** ANDA215641
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CLOTRIMAZOLE
- **Generic name:** CLOTRIMAZOLE
- **Active ingredients:** CLOTRIMAZOLE
- **Dosage form:** TROCHE/LOZENGE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** THINQ PHARM-CRO PVT
- **Manufacturer:** Rising Pharma Holdings, Inc.
- **First approval:** 2024-02-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215641)
---
*AI Analytics · CC0 1.0*